milrinone has been researched along with Retrolental Fibroplasia in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Milrinone is administered after patent ductus arteriosus (PDA) ligation to prevent and treat postoperative hemodynamic instability (i." | 1.91 | Effects of Milrinone on Neonates after Patent Ductus Arteriosus Ligation: A Retrospective Nationwide Database Study. ( Fujita, A; Ito, A; Kashima, K; Kato, M; Kitaoka, H; Konishi, T; Matsui, H; Shitara, Y; Takahashi, N; Yasunaga, H, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kitaoka, H | 1 |
| Konishi, T | 1 |
| Shitara, Y | 1 |
| Ito, A | 1 |
| Kashima, K | 1 |
| Fujita, A | 1 |
| Matsui, H | 1 |
| Kato, M | 1 |
| Takahashi, N | 1 |
| Yasunaga, H | 1 |
1 other study available for milrinone and Retrolental Fibroplasia
| Article | Year |
|---|---|
Effects of Milrinone on Neonates after Patent Ductus Arteriosus Ligation: A Retrospective Nationwide Database Study.
Topics: Bronchopulmonary Dysplasia; Cerebral Hemorrhage; Ductus Arteriosus, Patent; Enterocolitis, Necrotizi | 2023 |